Table 4.
Barcelona Clinic Liver Cancer C hepatocellular carcinoma, a broad spectrum of tumors; example of the Advanced Liver Cancer Prognostic System score[36]
| Parameters | Points |
| Ascites | 2 |
| Abdominal pain | 2 |
| Weight loss | 2 |
| Child-Pugh grade A/B/C | 0/2/5 |
| alkaline phosphatase, UI/L > 200 | 3 |
| Bilirubin, mcmol/L ≤ 33/> 33-≤ 50/> 50 | 0/1/3 |
| Urea, mmol/L > 8.9 | 2 |
| Portal vein thrombosis | 3 |
| Tumor size: Diffuse/> 5 cm/≤ 5 cm | 4/3/0 |
| Lung metastases | 3 |
| AFP, ng/mL > 400 | 4 |
| Probability of patients surviving at least 3 mo estimated by the ALCPS score[36] | |
| Score ≤ 8 points: 82.0% (95%CI: 76.5%-87.5%) | |
| Score 9-15 points: 53.4% (95%CI: 48.3%-57.7%) | |
| Score ≥ 16 points: 18.9% (95%CI: 14.7%-23.3%) |
Probability of patients surviving at least 3 mo estimated by the ALCPS score[36]. AFP: Alpha-fetoprotein; ALCPS: Advanced Liver Cancer Prognostic System.